S01AE07 - Moxifloxacin |
Not porphyrinogenic |
NP |
Side effects
Plasma concentrations are well below 1 µM (SPC) and hepatic exposure in therefore insignificant.
Rationale
Administered locally in the eye and systemic exposure is insignificant.
Chemical description
Fluoroquinolone antibiotic
Therapeutic characteristics
Moxifloxacin eye drops are used in the treatment of bacterial conjunctivitis.
Hepatic exposure
Moxifloxacin is metabolized mainly via sulfate or glucuronide conjugation, while the rest is excreted as the unchanged form. It is probably CYP450 independent (SPC).
Similar drugs
References
| # | Citation details | PMID |
|---|---|---|
| * | Summary of Product Characteristics | |
| 1. | The electronic Medicines Compendium (emc). Summary of Product Characteristics (SPC). Moxivig.
|
|
Tradenames
Moxifloxacine · Vigamox 
Kanavig 
Abimox · Moxifloxacino · Omnimoxa · Vigamox 
Vigamox 
Moxifloxacina · Vigamox 
Moxifloxacin · Vigamox 
Moxifloxacin · Moxivig 
Vamocin · Vigamox · Xiflodrop 
Vigamox 
Flomixa · Floxamic · Monafox · Moxifloxacinum · Vigamox 
Moxifloxacin · Vigamox 
Kanavig 
Vigamox 
Vigamox 
Ekara · Lifodrox · Vigamox 
Ekara · Lifodrox · Vigamox 
Flomixa · Lifodrox · Vigamox 
Elfonis · Moksacin · Vigamox 
Moksifloksacin · Vigamox